MORGAN MATLICK: Open Payments
NPI 1588446736 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 11 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $200 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $119 |
| Lundbeck LLC | 2 | $40 |
| Genentech USA, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Integra LifeSciences Corporation | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Penumbra, Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $14 |
Products named: SpyGlass Discover, VYEPTI, Ocrevus, KEVEYIS, AMYVID, CODMAN CERTAS, ELIQUIS, WAINUA.
Industry payments across OH — which companies pay providers there.
